Yoshida Sarcoma

06/01/1986 - "[Controlled release of adriamycin from silicone elastomer and its antitumor effects on Yoshida Sarcoma]."
01/01/1983 - "Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats."
04/01/1992 - "Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats."
01/01/2019 - "MR TPN with doxorubicin (DOX) and vincristine (VCR) resulted in significant tumor suppression and prolonged survival of Yoshida-sarcoma-bearing rats. "
01/01/1981 - "Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin."

01/01/1983 - "Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition."
01/01/1983 - "Magnetic albumin microspheres (1 micron average diameter) were selectively targeted to subcutaneous solid Yoshida sarcoma tumors (average size 450 mm2) in Holtzman rats. "
01/01/1983 - "Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats."
01/01/1981 - "Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin."
01/01/1983 - "Magnetically responsive albumin microspheres containing doxorubicin hydrochloride were selectively localized in Yoshida sarcoma tumors. "

11/01/1983 - "However, further centrifugation resulted in precipitation of the enzyme, the enzyme from Yoshida sarcoma ascites cells being precipitated more easily than that from rat liver. "
11/01/1983 - "II. Purification and properties of the enzyme from Yoshida sarcoma ascites tumor cells."
01/01/1975 - "Intracellular distribution of various enzymes concerned with DNA synthesis from normal and regenerating rat liver, and Yoshida sarcoma."
11/16/1973 - "A complex of various enzymes concerned with DNA synthesis in Yoshida sarcoma."
10/01/1967 - "Glucose-metabolizing enzymes in Yoshida sarcoma and its slow-growing variant subline."

08/01/1978 - "A crude extract of Yoshida sarcoma cells stimulated the nucleosomal template activity. "
06/01/1977 - "Deoxyuridine monophosphokinase, which is detectable in a crude extract of normal rat liver, could not be detected in an extract of Yoshida sarcoma cells. "
11/01/1983 - "With this improved assay method, the regulatory properties of the enzyme in crude extracts of liver and Yoshida sarcoma ascites cells were examined. "
04/01/1980 - "Yoshida sarcoma cells contain a factor that stimulates thymidine kinase activity in the liver of mice in vivo; intraperitoneal injection of an extract from Yoshida sarcoma into normal mice stimulated their liver thymidine kinase activity 2- to 3-fold, whereas injection of a crude extract of normal rat liver did not stimulate the activity at all. "
10/01/1987 - "On sucrose density gradient centrifugation of a crude extract of Yoshida sarcoma ascites cells, a part of this enzyme showed high sedimentability at low ionic strength. "

02/01/1971 - "Increase of adenosine triphosphatase activity of Yoshida sarcoma cells in the process of acquiring resistance to alkylating agents."
11/05/1984 - "The ATPase activity of Zajdela hepatoma and Yoshida sarcoma submitochondrial particles was several times lower than the enzyme activity in rat heart and rat liver submitochondrial particles. "
06/25/1975 - "Evidence obtained with Yoshida sarcoma cells, dog and human erythrocytes and three tissue culture cell lines KB (human oral carcinoma), Hela (human cervix carcinoma) and L-132 (human lung embryonic) shows that inhibition of (Na-++K-+)-ATPase by the P6 protein can be correlated with its lytic activity. "
01/01/1979 - "Phospholipase A2 from Naja naja which was most active in degrading phospholipids was least effective in inhibiting (Na+ + K+)-ATPase in Yoshida sarcoma cells or in beef brain microsomes. "
01/01/1979 - "Cytotoxin P6 which was most basic and devoid of phospholipase activity was most effective in inhibiting the (Na+ + K+)-ATPase of Yoshida sarcoma cells. "

07/01/1991 - "Expressed as micromoles of leucine per gram tissue, tumor protein breakdown increased (P less than 0.01) from 0.32 +/- 0.02 to 0.52 +/- 0.09 (SE) mumol/h, with progress of the Yoshida sarcoma tumor between days 10 and 13 after implantation. "
08/01/1978 - "In order to acquire a fundamental knowledge for the development of better tumor-scanning agents, the in vivo incorporation pattern of three 14C-labeled D-amino acids, alanine, leucine, and tryptophan, into the tumor cells and organs of animals bearing Ehrlich mouse tumor, sarcoma-180, leukemia L-1210, or Yoshida sarcoma was investigated, and compared with that of the corresponding L-forms. "
01/01/1980 - "The continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine, and valine (Leu-Ile-Val) to Yoshida sarcoma-bearing rats caused a significant increase in the survival time by 32% and a significant reduction of tumor size after 3 weeks of growth by 33%. "
07/01/1993 - "By using a transplantable Yoshida sarcoma in a rat total parenteral nutrition model, we measured the effectiveness of an arginine-enriched amino acid solution (AI-82) in terms of leucine kinetics and nitrogen balance as indicators of host-tumor nutrition interaction compared with that of a conventional amino acid solution (Proteamin12). "

01/01/1980 - "The behavior of toxin gamma, cytotoxin P6 and neurotoxin alpha on Yoshida sarcoma cells and human erythrocytes demonstrate that whereas cytotoxin P6 was more active in lysing Yoshida sarcoma cells the order of activity was reversed in the human erythrocytes. "
01/01/1979 - "Cytotoxin P6 which was most basic and devoid of phospholipase activity was most effective in inhibiting the (Na+ + K+)-ATPase of Yoshida sarcoma cells. "
01/01/1979 - "Inactivation of (Na+ + K+)-ATPase of Yoshida sarcoma cells and beef brain microsomes by phospholipase A2 and a cytotoxin P6 from snake venom has been examined in relation to their activity to degrade phospholipids. "
01/01/1979 - "The overall data obtained using purified (Na+ + K+)-stimulated ATPase of Yoshida sarcoma cells suggest that cytotoxin P6 combines with phosphatidyl serine and a glycolipid which are closely associated with (Na+ + K+)-stimulated ATPase which in turn may lead to the inactivation of the enzyme in this cell system."

06/15/1976 - "Administered intraperitoneally, they are more effective in inhibiting the ascites tumor growth (Ehrlich's carcinoma in mice and Yoshida sarcoma in rats) than procarbazine in vitro as well as in vivo. "
01/15/1977 - "The cytostatic activity of N'-methyl-N'-beta-chloroethylbenzaldehyd hydrazone (B1) is at least equal to that of procarbazine when its effect is tested with the Ehrlich ascites tumor cells of the mouse and the Yoshida sarcoma of the rat. "

01/01/1970 - "[Effects of glycemic agents combined with phospholipids on the growth of Yoshida sarcoma]."
01/01/1979 - "Phospholipase A2 from Naja naja which was most active in degrading phospholipids was least effective in inhibiting (Na+ + K+)-ATPase in Yoshida sarcoma cells or in beef brain microsomes. "
01/01/1979 - "Inactivation of (Na+ + K+)-ATPase of Yoshida sarcoma cells and beef brain microsomes by phospholipase A2 and a cytotoxin P6 from snake venom has been examined in relation to their activity to degrade phospholipids. "

05/15/1988 - "Effects of branched chain amino acid-enriched total parenteral nutrition on amino acid utilization in rats bearing Yoshida sarcoma."
01/01/1980 - "The continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine, and valine (Leu-Ile-Val) to Yoshida sarcoma-bearing rats caused a significant increase in the survival time by 32% and a significant reduction of tumor size after 3 weeks of growth by 33%. "

01/01/1983 - "Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition."
01/01/1983 - "Magnetic albumin microspheres (1 micron average diameter) were selectively targeted to subcutaneous solid Yoshida sarcoma tumors (average size 450 mm2) in Holtzman rats. "
01/01/1983 - "Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats."
01/01/1981 - "Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin."
01/01/1983 - "Magnetically responsive albumin microspheres containing doxorubicin hydrochloride were selectively localized in Yoshida sarcoma tumors. "

01/01/2019 - "MET-restricted total parenteral nutrition (MR TPN) was effective in Yoshida sarcoma-bearing rats. "
09/01/1990 - "Metabolic effects of medium chain triglyceride-enriched total parenteral nutrition in rats bearing Yoshida sarcoma."
01/01/1990 - "Effect of structured lipid-enriched total parenteral nutrition in rats bearing yoshida sarcoma."
02/01/1991 - "The effects of total parenteral nutrition containing alanylglutamine (Ala-Gln) on tumor growth and cellular immune response were examined in rats inoculated Yoshida sarcoma cells subcutaneously. "
04/01/1992 - "Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats."

12/01/1957 - "Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. "
12/01/1956 - "Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. "
12/01/1956 - "[Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. "
12/01/1956 - "Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. "
12/01/1956 - "Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. "

06/01/1968 - "[Experimental studies on transplantation of Yoshida Sarcoma into the oral cavity]."
09/01/1952 - "[Cytological study on the cycle of the morphological changes of Yoshida sarcoma cells in intraperitoneal transplantation]."
12/01/1950 - "Studies on the resistance to Yoshida sarcoma transplantation in several strains of rats sensitized with Yoshida sarcoma."
09/01/1955 - "[Transplantation of the Yoshida sarcoma by aspiration]."
09/01/1953 - "[Inhibiting effects of various compounds upon the transplantation of the Yoshida sarcoma]."

11/25/1967 - "I. Combined therapy on Yoshida sarcoma."
12/01/1951 - "On the immunological therapy of Yoshida sarcoma."
12/01/1950 - "On the influence of anti-Yoshida-sarcoma-sera of healed rats and sensitized rabbits upon neutralization, passive immunity and therapy of Yoshida sarcoma."
06/01/1995 - "The drug release rate in this therapy in vitro study was 50% after 24 hrs. When injected to rats bearing Yoshida sarcoma, it exhibited a marked antitumor effect compared to the control group given 5-FU alone. "
09/01/1952 - "Studies on the therapy of Yoshida sarcoma with chemicals and those combined with immune sera."